OBJECTIVE: The current study examined whether age after menopause impacted the effect of estradiol (E2) on mood after a psychosocial stress manipulation. BACKGROUND: Previous studies have shown that E2 improves mood in women around the menopause transition but does not improve mood for older postmenopausal women. We have previously shown that E2 treatment in nondepressed women resulted in increased negative mood after psychosocial stress. DESIGN:Participants were 22 postmenopausal women placed on eitheroral placebo or 17β-estradiol (1 mg/day for 1 month, then 2 mg/day for 2 months). METHOD: At the end of the 3-month treatment phase, the participants performed the Trier Social Stress Test followed by mood ratings. To examine the effects of age on the estrogen-stress interaction, we performed a median split on age and created four groups of participants: younger-placebo (mean age: 55.5 years), younger-E2 (mean age: 55.5 years), older-placebo (mean age: 73.0 years), and older-E2 (mean age: 76.8 years). RESULTS: : The results showed that both older and younger E2-treated participants exhibited a significant and similar increase in negative mood after psychosocial stress compared with placebo-treated women. CONCLUSIONS: These results suggest that E2 may play a significant role in modulating emotional reactivity to stressful events and that this effect persists in older women. Furthermore, responsivity to E2 effects on emotional processing appears to be intact even years after menopause in contrast with other cognitive and behavioral effects of E2, which may be limited to the early postmenopausal years.
RCT Entities:
OBJECTIVE: The current study examined whether age after menopause impacted the effect of estradiol (E2) on mood after a psychosocial stress manipulation. BACKGROUND: Previous studies have shown that E2 improves mood in women around the menopause transition but does not improve mood for older postmenopausal women. We have previously shown that E2 treatment in nondepressed women resulted in increased negative mood after psychosocial stress. DESIGN:Participants were 22 postmenopausal women placed on either oral placebo or 17β-estradiol (1 mg/day for 1 month, then 2 mg/day for 2 months). METHOD: At the end of the 3-month treatment phase, the participants performed the Trier Social Stress Test followed by mood ratings. To examine the effects of age on the estrogen-stress interaction, we performed a median split on age and created four groups of participants: younger-placebo (mean age: 55.5 years), younger-E2 (mean age: 55.5 years), older-placebo (mean age: 73.0 years), and older-E2 (mean age: 76.8 years). RESULTS: : The results showed that both older and younger E2-treated participants exhibited a significant and similar increase in negative mood after psychosocial stress compared with placebo-treated women. CONCLUSIONS: These results suggest that E2 may play a significant role in modulating emotional reactivity to stressful events and that this effect persists in older women. Furthermore, responsivity to E2 effects on emotional processing appears to be intact even years after menopause in contrast with other cognitive and behavioral effects of E2, which may be limited to the early postmenopausal years.
Authors: Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young Journal: Menopause Date: 2010-07 Impact factor: 2.953
Authors: G Ceresini; M Freddi; S Morganti; I Rebecchi; A B Modena; M Rinaldi; C Manca; A Amaducci; G Del Rio; G Valenti Journal: Am J Med Date: 2000-10-15 Impact factor: 4.965
Authors: Mary F Morrison; Michael J Kallan; Thomas Ten Have; Ira Katz; Kathryn Tweedy; Michelle Battistini Journal: Biol Psychiatry Date: 2004-02-15 Impact factor: 13.382
Authors: Megan R Gerber; Matthew W King; Suzanne L Pineles; Shannon Wiltsey-Stirman; Bevanne Bean-Mayberry; Sandra J Japuntich; Sally G Haskell Journal: J Gen Intern Med Date: 2014-11-06 Impact factor: 5.128
Authors: Mina Khaleghi; Mohammad Amin Rajizadeh; Hamideh Bashiri; Kristi Anne Kohlmeier; Fatemeh Mohammadi; Mohammad Khaksari; Mohammad Shabani Journal: Brain Behav Date: 2021-04-03 Impact factor: 2.708
Authors: Marta Balog; Senka Blažetić; Vedrana Ivić; Irena Labak; Bartosz Krajnik; Raquel Marin; Ana Canerina-Amaro; Daniel Pereda de Pablo; Ana Bardak; Robert Gaspar; Kálmán Ferenc Szűcs; Sandor G Vari; Marija Heffer Journal: Eur J Neurosci Date: 2021-05-14 Impact factor: 3.698
Authors: Stephen R Palmer; Annette Evans; Hannah Broughton; Simon Huddart; Mark Drayton; Judith Rankin; Elizabeth S Draper; Alan Cameron; Shantini Paranjothy Journal: PLoS One Date: 2013-11-08 Impact factor: 3.240